POSTNATAL-DEVELOPMENT OF MURINE SPLEEN-CELL PROLIFERATIVE RESPONSES INDUCED BY INTERLEUKIN-2 OR PHORBOL ESTER AND CALCIUM IONOPHORE-A23187

被引:5
作者
CUNNINGHAM, RK
ZHOU, P
ZALESKI, MB
机构
[1] SUNY BUFFALO,ERNEST WITEBSKY CTR IMMUNOL,BUFFALO,NY 14214
[2] SUNY BUFFALO,DEPT MICROBIOL,BUFFALO,NY 14214
关键词
D O I
10.1016/S0171-2985(11)80571-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the kinetics of the ontogeny of polygenically controlled proliferative responses, spleen cells from 5, 10 and 20 day-old mice, previously identified as high (B10 PL-Thy 1a, AKR.M) and low (C3H-A) responders were tested. Cells (10(5)) were stimulated in vitro with human recombinant IL-2 (35 U), a mixture of either IL-2 (0.7 U) and 13-myristate 12-acetate phorbol (5 ng) or phorbol and calcium ionophore A23187 (5 ng). Two parameters were assessed; proliferation measured by H-3-thymidine incorporation and the synergistic effect expressed as a synergism coefficient (SC): the ratio of proliferation induced by a mixture to the sum of proliferations induced by each component alone. At the age of 5 days, all three strains, regardless of stimulation, produced similar proliferation and showed no synergistic effect (SC - 1.0). At the age of 10 days, proliferation of high responder cells was 3-5 times higher than that of the low responder, but only high responders displayed marginal synergistic effect (2 > SC > 1.5). At the age of 20 days, proliferative responses of the high responders increased somewhat and a definitive synergistic effect became clearly demonstrable (SC > 3.0). This effect increased further after the age of 20 days to reach the level of SC > 5.0 in adult high responders. The delay in expression of synergistic effect was due to a substantial proliferation induced by phorbol alone in 10 day-old animals. The available data allow the conclusion that phenotypic strain variation in proliferative responses is first detectable at the age of 10 days and becomes fully developed only after attaining the age of 20 days or more. Since the magnitude of proliferative responses was not associated with frequencies of 11-2R alpha(1) cells it seems that differences in responsiveness can not be attributed to the induction of IL 2R alpha chain, and they may reflect intrinsic abilities of cells to proliferate.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 20 条
[1]   MITOGENIC EFFECT OF ALPHA-1-MICROGLOBULIN ON MOUSE LYMPHOCYTES - EVIDENCE OF T-CELL AND B-CELL COOPERATION, B-CELL PROLIFERATION, AND A LOW-AFFINITY RECEPTOR ON MONONUCLEAR-CELLS [J].
BABIKERMOHAMED, H ;
AKERSTROM, B ;
LOGDBERG, L .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (01) :37-44
[2]  
BLUE ML, 1987, J IMMUNOL, V139, P3949
[3]   CHARACTERIZATION OF THE MURINE ANTIGENIC DETERMINANT, DESIGNATED L3T4A, RECOGNIZED BY MONOCLONAL-ANTIBODY GK1.5 - EXPRESSION OF L3T4A BY FUNCTIONAL T-CELL CLONES APPEARS TO CORRELATE PRIMARILY WITH CLASS II MHC ANTIGEN-REACTIVITY [J].
DIALYNAS, DP ;
WILDE, DB ;
MARRACK, P ;
PIERRES, A ;
WALL, KA ;
HAVRAN, W ;
OTTEN, G ;
LOKEN, MR ;
PIERRES, M ;
KAPPLER, J ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1983, 74 :29-56
[4]   STRAIN DIFFERENCES IN THE RESPONSE OF NORMAL MURINE SPLEEN-CELLS TO INTERLEUKIN-2 (IL-2) [J].
DOWJAT, WK ;
QUACKENBUSH, LJ ;
ZALESKI, MB .
IMMUNOLOGICAL INVESTIGATIONS, 1985, 14 (06) :493-501
[5]   HIV-1, HTLV-1 AND NORMAL T-CELL GROWTH - TRANSCRIPTIONAL STRATEGIES AND SURPRISES [J].
GREENE, WC ;
BOHNLEIN, E ;
BALLARD, DW .
IMMUNOLOGY TODAY, 1989, 10 (08) :272-278
[6]   XENOGENEIC MONOCLONAL ANTIBODIES TO MOUSE LYMPHOID DIFFERENTIATION ANTIGENS [J].
LEDBETTER, JA ;
HERZENBERG, LA .
IMMUNOLOGICAL REVIEWS, 1979, 47 :63-90
[7]   IDENTIFICATION AND INITIAL CHARACTERIZATION OF A RAT MONOCLONAL-ANTIBODY REACTIVE WITH THE MURINE INTERLEUKIN-2 RECEPTOR LIGAND COMPLEX [J].
MALEK, TR ;
ROBB, RJ ;
SHEVACH, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5694-5698
[8]  
RACE RR, 1975, BLOOD GROUPS MAN, P448
[9]   INTERLEUKIN-2 BINDING MOLECULE DISTINCT FROM THE TAC PROTEIN - ANALYSIS OF ITS ROLE IN FORMATION OF HIGH-AFFINITY RECEPTORS [J].
ROBB, RJ ;
RUSK, CM ;
YODOI, J ;
GREENE, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (07) :2002-2006
[10]   IMMUNOTHERAPY OF CANCER USING INTERLEUKIN-2 - CURRENT STATUS AND FUTURE-PROSPECTS [J].
ROSENBERG, SA .
IMMUNOLOGY TODAY, 1988, 9 (02) :58-62